Nitric oxide donors and uses thereof

Details Nitric oxide donors and uses thereof Nitric oxide donors and uses thereof

2011-06-28

2011-06-28

Loewe, Sun Jae Y (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S202000

Reexamination Certificate

active

07968575

ABSTRACT:
Disclosed are novel NO-donating compounds, designed such that when NO is released from the compound a residue which is a naturally occurring metabolite is formed, and thus a development of tolerance to the compounds upon repetitive administration is prevented or decreased. Also disclosed are methods of preparing such NO-donating compounds, pharmaceutical compositions and medical devices containing such compounds and methods utilizing such compounds in the treatment of various medical conditions.

REFERENCES:
patent: 4505857 (1985-03-01), Egli
patent: 4923886 (1990-05-01), Shiokawa et al.
patent: 5404871 (1995-04-01), Goodman et al.
patent: 5542410 (1996-08-01), Goodman et al.
patent: 5807847 (1998-09-01), Thatcher et al.
patent: 5874063 (1999-02-01), Briggner et al.
patent: 5883122 (1999-03-01), Thatcher et al.
patent: 5983956 (1999-11-01), Trofast
patent: 6221398 (2001-04-01), Jakupovic et al.
patent: 6268533 (2001-07-01), Gao et al.
patent: 6310052 (2001-10-01), Thatcher et al.
patent: 6488951 (2002-12-01), Toone et al.
patent: 6552047 (2003-04-01), Garvey et al.
patent: 6566324 (2003-05-01), Nadel et al.
patent: 6571790 (2003-06-01), Weinstein
patent: 6637430 (2003-10-01), Voges et al.
patent: 6652323 (2003-11-01), Yanda
patent: 6916835 (2005-07-01), Thatcher et al.
patent: 7189750 (2007-03-01), Assaf et al.
patent: 7368577 (2008-05-01), Assaf et al.
patent: 2002/0177622 (2002-11-01), Thatcher et al.
patent: 2005/0137191 (2005-06-01), Thatcher et al.
patent: 2008/0233163 (2008-09-01), Assaf
patent: 0452782 (1991-10-01), None
patent: WO 99/55319 (1999-04-01), None
patent: WO 00/30614 (2000-02-01), None
patent: WO 01/49275 (2001-07-01), None
patent: WO 03/086282 (2003-10-01), None
patent: WO2005/105065 (2005-11-01), None
Silberg et al., caplus an 1965:88847.
Schonafinger, Heterocyclic NO prodrugs, II Farmaco, 54 (1999), 316-320.
Munzel, JACC, 2001, 38, 1102-1105.
Thatcher et al, caplus an 2005:547257.
U.S. Appl. No. 09/473,713, filed Dec. 29, 1999, Thatcher et al.
Kumar et al. “Design, Synthesis, and Evaluation of α-Ketoheterocycles as Class C β-Lactamase Inhibitors”, Bioorganic & Medicinal Chemistry, 9: 2035-2044, 2001.
Cavicchi et al. “Inhibition of Inducible Nitric Oxide Synthase in the Human Intestinal Epithelial Cell Line, DLD-1, by the Inducers of Heme Oxygenase 1, Bismuth Salts, Heme, and Nitric Oxide Donors”, GUT, 47(6): 771-778, 2000. Abstract.
Salas et al. “Nitric Oxide Supplementation Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice”, Laboratory Investigation, 82(5): 597-607, 2002. Abstract, p. 602, col. 1, Lines 3-19.
Ueda et al. “Structure-Activity Relationships of 2-Aminothiazole Derivatives as Inducible Nitric Oxide Synthase Inhibitor”, Chemical & Pharmaceutical Bulletin, 52(5): 634-637, 2004. Abstract, p. 634, col. 2, Last Line—p. 635, col. 1, Line 2, Table 2, Expls. 5a, 5b, 7, p. 636, col. 1, Lines 17-18, 25-39.
Münzel et al. “Evidence fpr Enhanced Vascular Superpxide Anion Production”, The Journal of Clinical Investigation, 95: 187-194, 1995.
Chung et al. Identification of the Subcellular Site for Nitroglycerin Metabolism to Nitric Oxide in Bovine Coronary Smoth Muscle Cells, The Journal of Pharmacology and Experimental Therapeutics, 253(2): 614-619, 1990.
McGuire et al. “Inhibition of NADPH-Cytochrome P450 Reductase and Glyceryl Trinitrate Biotransformation by Diphenyleneidononium Sulfate”, Biochemical Pharmacology, 56: 881-893, 1998.
Needleman et al. “Sulfhydryl Requirement for Relaxation of Vascular Smooth Muscle”, The Journal of Pharmacology and Experimental Therapeutics, 187(2): 324-331, 1973.
Bueb et al. “Natural Polyamines Stimulate G-Proteins”, Biochemical Journal, 282: 545-550, 1992.
Loscalzo “N-Acetylcysteine Potentiates Inhibition of Platelet Aggregation by Nitroglycerin”, Journal of Clinical Investigation, 76: 703-708, 1985.
Kurz et al. “Nitroglycerin Metabolism in Vascular Tissue: Role of Glutathione S-Transferases and Relationship Between NO and NO2-Formation”, Biochemical Journal, 292: 545-550, 1993.
Official Action Dated Jan. 4, 2007 From the US Patent Office Re.: U.S. Appl. No. 11/266,346.
Official Action Dated Oct. 12, 2007 From the US Patent Office Re.: U.S. Appl. No. 11/266,346.
Official Action Dated Oct. 17, 2008 From the US Patent Office Re.: U.S. Appl. No. 11/266,346.
International Search Report Dated Aug. 16, 2005 From the International Searching of the Patent Cooperation Treaty Authority Re.: Application No. PCT/IL2005/000481.
Official Action Dated Jul. 31, 2007 From the US Patent and Trademark Office U.S. Appl. No. 11/266,464.
International Preliminary Report on Patentability Dated Apr. 20, 2006 From the International Preliminary Examining Authority Re.: Application No. PCT/IL2005/000481.
Official Action Dated Apr. 3, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/266,431.
Official Action Dated Apr. 4, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/266,346.
Official Action Dated Jan. 14, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/266,346.
Official Action Dated Oct. 17, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/266,346.
Official Action Dated Sep. 26, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/266,431.
Official Action Dated Apr. 28, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/266,441.
Official Action Dated May 30, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/266,443.
Official Action Dated Sep. 29, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 12/076,828.
International Search Report Dated Nov. 2, 2005 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL2005/000480.
Notice of Allowance Dated Oct. 10, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/266,424.
Official Action Dated Jun. 11, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/266,424.
Official Action Dated May 16, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/266,424.
Written Opinion Dated Nov. 2, 2005 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL2005/000480.
Written Opinion Dated Aug. 16, 2005 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL2005/000481.
Cavicchi et al. “Inhibition of Inducible Nitric Oxide Synthase in the Human Intestinal Epithelial Cell Line, DLD-1, by the Inducers of Heme Oxygenase 1, Bismuth Salts, Heme, and Nitric Oxide Donors”, GUT, 47(6): 771-778, 2000. Abstract.
Golub et al. “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, 286: 531-537, 1999.
Golub et al. “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, 286: 531-537, 1999.

Affiliated with

Also associated with

Rating

Nitric oxide donors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nitric oxide donors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitric oxide donors and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2703215